1. Nat Commun. 2022 Jul 22;13(1):4239. doi: 10.1038/s41467-022-31837-9.

Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas 
aeruginosa infection.

Ferry T(1)(2)(3)(4), Kolenda C(5)(6)(7)(8), Laurent F(5)(6)(7)(8), Leboucher 
G(9), Merabischvilli M(10), Djebara S(10), Gustave CA(5)(7)(8), Perpoint T(11), 
Barrey C(12), Pirnay JP(#)(10), Resch G(#)(13).

Author information:
(1)Service de Maladies Infectieuses et Tropicales, Hôpital de la Croix-rousse, 
Hospices Civils de Lyon, Lyon, France. tristan.ferry@univ-lyon1.fr.
(2)Université Claude Bernard Lyon 1, Villeurbanne, France. 
tristan.ferry@univ-lyon1.fr.
(3)Centre de Référence des Infections Ostéo-Articulaires Complexes de Lyon 
(CRIOAc Lyon), Hospices Civils de Lyon, Lyon, France. 
tristan.ferry@univ-lyon1.fr.
(4)Centre International de Recherche en Infectiologie, CIRI, Inserm U1111, CNRS 
UMR5308, ENS de Lyon, UCBL1, Lyon, France. tristan.ferry@univ-lyon1.fr.
(5)Université Claude Bernard Lyon 1, Villeurbanne, France.
(6)Centre de Référence des Infections Ostéo-Articulaires Complexes de Lyon 
(CRIOAc Lyon), Hospices Civils de Lyon, Lyon, France.
(7)Centre International de Recherche en Infectiologie, CIRI, Inserm U1111, CNRS 
UMR5308, ENS de Lyon, UCBL1, Lyon, France.
(8)Institut des Agents Infectieux, Hôpital de la Croix-rousse, Hospices Civils 
de Lyon, Lyon, France.
(9)Pharmacie Hospitalière, Hôpital de la Croix-rousse, Hospices Civils de Lyon, 
Lyon, France.
(10)Laboratory for Molecular and Cellular Technology, Queen Astrid Military 
Hospital, 1120, Brussels, Belgium.
(11)Service de Maladies Infectieuses et Tropicales, Hôpital de la Croix-rousse, 
Hospices Civils de Lyon, Lyon, France.
(12)Service de Neurochirurgie, Chirurgie du Rachis et de la Moëlle Épinière, 
Hôpital Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France.
(13)Centre of Research and Innovation in Clinical Pharmaceutical Sciences, 
Lausanne University Hospital, Lausanne, Switzerland.
(#)Contributed equally

Bone and joint infections (BJI) are one of the most difficult-to-treat bacterial 
infection, especially in the era of antimicrobial resistance. Lytic 
bacteriophages (phages for short) are natural viruses that can selectively 
target and kill bacteria. They are considered to have a high therapeutic 
potential for the treatment of severe bacterial infections and especially BJI, 
as they also target biofilms. Here we report on the management of a patient with 
a pandrug-resistant Pseudomonas aeruginosa spinal abscess who was treated with 
surgery and a personalized combination of phage therapy that was added to 
antibiotics. As the infecting P. aeruginosa strain was resistant to the phages 
developed by private companies that were contacted, we set up a unique European 
academic collaboration to find, produce and administer a personalized phage 
cocktail to the patient in due time. After two surgeries, despite bacterial 
persistence with expression of small colony variants, the patient healed with 
local and intravenous injections of purified phages as adjuvant therapy.

© 2022. The Author(s).

DOI: 10.1038/s41467-022-31837-9
PMCID: PMC9306240
PMID: 35869081 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare no competing interests.